At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 102 enrolled
Drug / intervention
Epidural +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Non-inferiority Trial of Continuous Thoracic Epidural Analgesia Versus Single Intercostal Nerve Block After Thoracotomy
In Brief
A Phase 4 clinical trial evaluating Epidural and Intercostal Bupivicaine (Exparel) for Pain Following Thoracotomy Surgery. Completed, enrolled 102 participants across 1 site.
Detailed Summary
Unilateral intercostal nerve blocks provide pain control as effectively as a continuous thoracic epidural, and will a lower incidence of side effects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain Following Thoracotomy Surgery
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 2014
Enrollment StartOct 2014
Primary CompletionOct 2018
Study CompletionJan 2019
TodayJul 2026
First PostedJul 1, 2014
Enrollment StartOct 15, 2014
Primary CompletionOct 9, 2018
Study CompletionJan 25, 2019
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 12.0 years ago
Interventions
Epiduraldrug
Intercostal Bupivicaine (Exparel)drug